Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation

Clinical trial NCT01326728 · TERMINATED

Trial details

NCT number: NCT01326728
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Study type: OBSERVATIONAL

Chronic Myelogenous Leukemia Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma

Start date: 2011-03-30
Primary completion: 2017-06-28
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.